Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2780 Intracardiac Paragangliomas (PGLs): A Single-Institution Experience

Introduction: Intracardiac PGLs are extremely rare neuroendocrine tumors. There are few reported series in literature, indicating surgery as the most effective treatment modality.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Rossi M, Bora G, Lanza G, Meda S, Olivetti S,

Keywords: Intracardiac paraganglioma,

#2065 Sunitinib in Patients with Pre-Treated Pancreatic Neuroendocrine Tumors: A Real-World Study

Introduction: Besides data reported in a Phase-III trial, data on sunitinib in pancreatic Neuroendocrine Tumors (panNETs) are scanty.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Rinzivillo M

Authors: Rinzivillo M, Gritti S, Pusceddu S, Spallanzani A, Ibrahim T,

Keywords: Sunitinib, neuroendocrine tumors, pancreas, progressive disease, target therapy,

#1907 Pancreatic Neuroendocrine Tumors in MEN1 Disease: A Monocentrice Longitudinal and Prognostic Study

Introduction: In MEN1+ patients (MEN+), pNETs are considered to be high risk for multiple, malignant and aggressive tumors.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Chiloiro S

Authors: Chiloiro S, Bianchi A, Lanza F, Schinzari G, Bima C,

Keywords: pNETs, MEN, prognosis,

#1013 Evaluation of VEGF and Endocan/ESM-1 Expression in pNETs and Correlation with Ki-67 and Prognosis

Introduction: Endocan has been reported as specific of endothelial tumor cells and was shown to be expressed by tip cells during the angiogenesis process.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Lugli F

Authors: Lugli F, Iacovazzo D, Lanza P, Inzani F, De Waure C,

Keywords: GEP-NET, Endocan, VEGF,

#987 Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional MRI in Pancreatic Neuroendocrine Tumors and Comparison with 68Ga-DOTANOC PET/CT

Introduction: Pancreatic neuroendocrine tumors (pNETs) are often difficult to detect because of small size and have variable prognosis related to grading and staging.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Lanza F

Authors: Farchione A, Rufini V, Brizi M, Lanza F, Iacovazzo D,

Keywords: neuroendocrine tumors, MRI, DWI, PET,